Recent Annual Reports

Browse the latest SEC filings with AI-powered analysis. Get insights into corporate performance, financial trends, and business developments.

📊 3910 Reports
🤖 AI Analyzed
Recent
📄 Page 204 of 326

Key Highlights

  • Reported a positive $11 million unrealized gain on investments for 2025, signali...
  • Specializes in providing 1st Lien/Secured Loans to companies underserved by trad...
  • Achieves attractive yields, with some loans reported as high as 14-15% and a spe...
Read Analysis
🤖 AI Generated

Key Highlights

  • Stable performance with 93% of the loan portfolio by balance remaining current o...
  • Successful resolution and full payment received for one previously troubled loan...
  • Diversified portfolio of 45 commercial mortgage loans with a total outstanding b...
Read Analysis
🤖 AI Generated

Key Highlights

  • Proprietary Therapeutic Vector Evolution platform for optimized gene delivery an...
  • Strong cash position of $300.8 million at year-end 2025, providing an estimated ...
  • Significant revenue growth to $75.2 million in 2025, primarily driven by collabo...
Read Analysis
🤖 AI Generated

Key Highlights

  • Stable performance of major loans like Prudential Plaza and 11 Madison Avenue pr...
  • The trust met all its regulatory reporting obligations for the year.
  • The portfolio is diversified across various property types (office, retail, indu...
Read Analysis
🤖 AI Generated

Key Highlights

  • The trust's outstanding principal balance has amortized to approximately $850 mi...
  • The weighted average DSCR remains healthy at 1.50x, and the weighted average LTV...
  • Credit enhancement for the senior-most tranches has increased to 25%, providing ...
Read Analysis
🤖 AI Generated

Key Highlights

  • The Trust holds a diversified portfolio of commercial mortgage loans.
  • Outstanding balance has significantly decreased from its initial $1.2 billion du...
  • Distributed a total of $C million to certificate holders for the fiscal year end...
Read Analysis
🤖 AI Generated
Moleculin Biotech, Inc.
10-K March 18, 2026

Key Highlights

  • Advancing innovative small molecule drugs for difficult-to-treat cancers and vir...
  • Lead drug candidates are progressing through various phases of clinical trials.
  • Secured essential funding to advance its clinical pipeline despite a challenging...
Read Analysis
🤖 AI Generated

Key Highlights

  • Successfully collected all scheduled principal and interest payments in FY2023.
  • Maintained consistent distributions to certificate holders.
  • Achieved overall financial stability compared to the prior fiscal year.
Read Analysis
🤖 AI Generated

Key Highlights

  • The Trust holds a diversified portfolio of commercial mortgage loans, offering i...
  • Maintained a generally stable payment record, successfully collecting and distri...
  • Experienced a full payoff of the AG Life Time Fitness Portfolio Mortgage Loan in...
Read Analysis
🤖 AI Generated
CD 2016-CD1 Mortgage Trust
10-K March 18, 2026

Key Highlights

  • Achieved stable financial performance and asset value in 2023 despite market flu...
  • Maintained a diversified commercial mortgage portfolio with strong payment perfo...
  • Performing loans show healthy weighted average Debt Service Coverage Ratio (DSCR...
Read Analysis
🤖 AI Generated

Key Highlights

  • Provides investors income from a diversified pool of commercial mortgage loans.
  • Holds interests in loans secured by prominent properties such as Vertex Pharmace...
  • Servicers proactively engage with borrowers facing financial difficulties to mit...
Read Analysis
🤖 AI Generated
Datavault AI Inc.
10-K March 18, 2026

Key Highlights

  • Achieved 73% revenue growth to $5.2 million, driven by initial licensing agreeme...
  • Secured a landmark $50 million multi-year agreement with IBM for its Sanqtum AI ...
  • Specializes in secure, decentralized AI-powered data management and analytics so...
Read Analysis
🤖 AI Generated

Stay Informed with AI Analysis

Get comprehensive insights from annual reports with our AI-powered analysis. Track corporate performance, financial trends, and strategic developments.

Back to Homepage